Ji F, Yan K, Ding B, Zhu Y, et al. Dual-target CAR-T therapy for ovarian cancer: synergistic targeting of MSLN and B7H3 enhances anti-tumor efficacy and overcomes antigen heterogeneity. Oncogene 2025 Dec 17. doi: 10.1038/s41388-025-03663.
PMID: 41408462